XML 92 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Financial Information (Schedule Of Condensed Consolidating Statements Of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Schedule Of Supplemental Financial Information [Line Items]    
Net cash (used in) provided by operating activities of continuing operations $ (3,785) $ 5,269
Net cash used in operating activities of discontinued operations 0 (7)
Net cash (used in) provided by operating activities (3,785) 5,262
Purchases of property, plant, and equipment (11,498) (4,741)
Cash paid for acquisitions, net of cash acquired 0 (146)
Other investing activities 121 0
Net proceeds from sale of property and equipment 5,950 247
Net cash used in investing activities (5,427) (4,640)
Long-term debt payments (407) (205,080)
Proceeds from long-term debt 0 210,000
Payment of note redemption fees 0 (3,702)
Purchase of treasury stock at market prices (408) (636)
Payment of deferred financing costs 0 (3,755)
Net proceeds from issuance of common stock 404 336
Intercompany financing 0 0
Excess tax benefit from stock compensation 81 62
Net cash used in financing activities (330) (2,775)
Effect of exchange rate changes on cash 260 (1,238)
Net decrease in cash and cash equivalents (9,282) (3,391)
Cash and cash equivalents at beginning of year 97,039 48,028
Cash and cash equivalents at end of period 87,757 44,637
Gibraltar Industries, Inc.
   
Schedule Of Supplemental Financial Information [Line Items]    
Net cash (used in) provided by operating activities of continuing operations   (2,905)
Net cash used in operating activities of discontinued operations   0
Net cash (used in) provided by operating activities (6,664) (2,905)
Purchases of property, plant, and equipment 0 0
Cash paid for acquisitions, net of cash acquired   0
Other investing activities 0  
Net proceeds from sale of property and equipment 0 0
Net cash used in investing activities 0 0
Long-term debt payments 0 (204,000)
Proceeds from long-term debt   210,000
Payment of note redemption fees   (3,702)
Purchase of treasury stock at market prices (408) (636)
Payment of deferred financing costs   (3,755)
Net proceeds from issuance of common stock 404 336
Intercompany financing 6,587 4,600
Excess tax benefit from stock compensation 81 62
Net cash used in financing activities 6,664 2,905
Effect of exchange rate changes on cash 0 0
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of year 0 0
Cash and cash equivalents at end of period 0 0
Guarantor Subsidiaries
   
Schedule Of Supplemental Financial Information [Line Items]    
Net cash (used in) provided by operating activities of continuing operations   7,090
Net cash used in operating activities of discontinued operations   (7)
Net cash (used in) provided by operating activities 272 7,083
Purchases of property, plant, and equipment (9,232) (3,533)
Cash paid for acquisitions, net of cash acquired   (146)
Other investing activities 121  
Net proceeds from sale of property and equipment 5,947 247
Net cash used in investing activities (3,164) (3,432)
Long-term debt payments (407) (1,080)
Proceeds from long-term debt   0
Payment of note redemption fees   0
Purchase of treasury stock at market prices 0 0
Payment of deferred financing costs   0
Net proceeds from issuance of common stock 0 0
Intercompany financing (6,028) (4,095)
Excess tax benefit from stock compensation 0 0
Net cash used in financing activities (6,435) (5,175)
Effect of exchange rate changes on cash 0 0
Net decrease in cash and cash equivalents (9,327) (1,524)
Cash and cash equivalents at beginning of year 75,856 26,163
Cash and cash equivalents at end of period 66,529 24,639
Non-Guarantor Subsidiaries
   
Schedule Of Supplemental Financial Information [Line Items]    
Net cash (used in) provided by operating activities of continuing operations   1,084
Net cash used in operating activities of discontinued operations   0
Net cash (used in) provided by operating activities 2,607 1,084
Purchases of property, plant, and equipment (2,266) (1,208)
Cash paid for acquisitions, net of cash acquired   0
Other investing activities 0  
Net proceeds from sale of property and equipment 3 0
Net cash used in investing activities (2,263) (1,208)
Long-term debt payments 0 0
Proceeds from long-term debt   0
Payment of note redemption fees   0
Purchase of treasury stock at market prices 0 0
Payment of deferred financing costs   0
Net proceeds from issuance of common stock 0 0
Intercompany financing (559) (505)
Excess tax benefit from stock compensation 0 0
Net cash used in financing activities (559) (505)
Effect of exchange rate changes on cash 260 (1,238)
Net decrease in cash and cash equivalents 45 (1,867)
Cash and cash equivalents at beginning of year 21,183 21,865
Cash and cash equivalents at end of period 21,228 19,998
Eliminations
   
Schedule Of Supplemental Financial Information [Line Items]    
Net cash (used in) provided by operating activities of continuing operations   0
Net cash used in operating activities of discontinued operations   0
Net cash (used in) provided by operating activities 0 0
Purchases of property, plant, and equipment 0 0
Cash paid for acquisitions, net of cash acquired   0
Other investing activities 0  
Net proceeds from sale of property and equipment 0 0
Net cash used in investing activities 0 0
Long-term debt payments 0 0
Proceeds from long-term debt   0
Payment of note redemption fees   0
Purchase of treasury stock at market prices 0 0
Payment of deferred financing costs   0
Net proceeds from issuance of common stock 0 0
Intercompany financing 0 0
Excess tax benefit from stock compensation 0 0
Net cash used in financing activities 0 0
Effect of exchange rate changes on cash 0 0
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of year 0 0
Cash and cash equivalents at end of period $ 0 $ 0